Companies

Zenas BioPharma, Inc. (ZBIO) SEC filings

CIK 0001953926 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)10.0 M50.0 M
Net income (USD)-377.7 M-37.1 M
Diluted EPS (USD/shares)-8.44-24.25

Latest filings

FiledFormDescriptionPeriod
2026-10-138-KFORM 8-K items 7.01,9.012026-10-12
2026-09-11S-3ASRS-3ASR
2026-09-11S-8FORM S-8
2026-09-08SCHEDULE 13GSCHEDULE 13G
2026-09-08332026-08-26
2026-09-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-024OWNERSHIP DOCUMENT2026-09-01
2026-09-023OWNERSHIP DOCUMENT2026-09-01
2026-08-19SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-19144144
2026-08-17SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-1310-Q10-Q2026-06-30
2026-08-138-KFORM 8-K items 2.02,5.02,9.012026-08-12
2026-06-17442026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-06-174OWNERSHIP DOCUMENT2026-06-15
2026-05-184OWNERSHIP DOCUMENT2026-05-18
2026-05-1310-Q10-Q2026-03-31

Forms on file (last 1,000): 4 62, 8-K 20, 3 19, SCHEDULE 13D/A 7, S-8 6, SCHEDULE 13G/A 6, 10-Q 6, DRSLTR 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ZBIO (0.002 USD), /gw/filings/filings?ticker=ZBIO&form=8-K, /gw/filings/facts?ticker=ZBIO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange